| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | XNSE Exchange | INE475E01026 ISIN |
| India Country | 1,642 Employees | - Last Dividend | 19 Oct 2016 Last Split | - IPO Date |
Caplin Point Laboratories Limited is a distinguished entity in the pharmaceutical domain, actively involved in the development, production, marketing, and export of generic pharmaceutical formulations along with branded products primarily within India. Since its inception in 1990, Caplin Point has consistently expanded its footprint, excelling in the pharmaceutical sector by leveraging its comprehensive suite of products and state-of-the-art manufacturing capabilities. With its headquarters located in Chennai, India, the company has built a reputation for its commitment to quality, innovation, and accessibility in healthcare solutions, reaching out to a broad spectrum of patients and healthcare providers not only domestically but across the globe.
Caplin Point Laboratories Limited offers a diverse range of pharmaceutical products and services, designed to cater to various healthcare needs. Below is an overview of their key offerings: